#154816

Anti-CD79a [HM47] rAb

Cat. #154816

Anti-CD79a [HM47] rAb

Cat. #: 154816

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: CD79a

Class: Recombinant

Reactivity: Bovine ; Chicken ; Horse ; Human ; Guinea Pig ; Mouse ; Opossum ; Pig ; Primate ; Rat ; Rabbit

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Absolute Antibody; University of Oxford

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-CD79a [HM47] rAb
  • Alternate name: B-cell antigen receptor complex-associated protein alpha chain; Ig-alpha; MB-1 membrane glycoprotein; Membrane-bound immunoglobulin-associated protein; Surface IgM-associated protein
  • Clone: HM47
  • Tool sub type: Primary antibody
  • Class: Recombinant
  • Conjugation: Unconjugated
  • Reactivity: Bovine ; Chicken ; Horse ; Human ; Guinea Pig ; Mouse ; Opossum ; Pig ; Primate ; Rat ; Rabbit
  • Host: Mouse
  • Description: The B cell Antigen receptor constitutes a disulphide linked heterodimer, consisting of CD79a / mb1 and CD79b / B29 polypeptides, non covalently associated with membrane bound immunoglobulins on B cells. CD79a first appears at pre B cell stage and persists until the plasma cell stage where it is found as an intracellular component. CD79a is found in B cell lymphomas, in B cell lines, the majority of acute leukemias of precursor B cell type and in some myelomas. The CD79a/b heterodimer interacts with at least one tyrosine kinase (Lyn). Induction of tyrosine kinase activity after antigen binding causes phosphorylation of the CD79a/b dimer, and also of other molecules, thereby initiating intracellular signaling. CD79a is widely used as an adjunct to CD20 for detecting normal and neoplastic B cells in tissues sections.
  • Immunogen: Synthetic peptide of 14 amino acids representing amino acids 202-216 of the human mb-1 cDNA sequence
  • Isotype: IgG1

Target Details

  • Target: CD79a
  • Target background: The B cell Antigen receptor constitutes a disulphide linked heterodimer, consisting of CD79a / mb1 and CD79b / B29 polypeptides, non covalently associated with membrane bound immunoglobulins on B cells. CD79a first appears at pre B cell stage and persists until the plasma cell stage where it is found as an intracellular component. CD79a is found in B cell lymphomas, in B cell lines, the majority of acute leukemias of precursor B cell type and in some myelomas. The CD79a/b heterodimer interacts with at least one tyrosine kinase (Lyn). Induction of tyrosine kinase activity after antigen binding causes phosphorylation of the CD79a/b dimer, and also of other molecules, thereby initiating intracellular signaling. CD79a is widely used as an adjunct to CD20 for detecting normal and neoplastic B cells in tissues sections.

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Brouns et al. 1993. Eur J Immunol. 23(5):1088-97. PMID: 8477803.
  • Evidence for a direct physical interaction of membrane IgM, IgD, and IgG with the B29 gene product.
  • Lankester et al. 1994. J Immunol. 152(5):2157-62. PMID: 8133032.
  • Mason et al. 1991. J Immunol. 147(11):2474-82. PMID: 1747162.
  • The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells.
  • The membrane IgM-associated heterodimer on human B cells is a newly defined B cell antigen that contains the protein product of the mb-1 gene.
  • The structure of the mu/pseudo light chain complex on human pre-B cells is consistent with a function in signal transduction.
  • van Noesel et al. 1991. J Immunol. 146(11):3881-8. PMID: 2033258.